- Home
- FENC vs NKSH Comparison
FENC vs NKSH Comparison
Compare FENC & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- NKSH
- Stock Information
- Founded
- FENC 1996
- NKSH 1891
- Country
- FENC United States
- NKSH United States
- Employees
- FENC N/A
- NKSH N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- NKSH Major Banks
- Sector
- FENC Health Care
- NKSH Finance
- Exchange
- FENC Nasdaq
- NKSH Nasdaq
- Market Cap
- FENC 156.9M
- NKSH 162.0M
- IPO Year
- FENC 2001
- NKSH N/A
- Fundamental
- Price
- FENC $5.95
- NKSH $26.14
- Analyst Decision
- FENC Strong Buy
- NKSH Strong Buy
- Analyst Count
- FENC 2
- NKSH 1
- Target Price
- FENC $14.00
- NKSH $38.00
- AVG Volume (30 Days)
- FENC 50.4K
- NKSH 11.1K
- Earning Date
- FENC 05-20-2025
- NKSH 05-19-2025
- Dividend Yield
- FENC N/A
- NKSH 5.84%
- EPS Growth
- FENC N/A
- NKSH N/A
- EPS
- FENC N/A
- NKSH 1.38
- Revenue
- FENC $47,538,000.00
- NKSH $46,211,000.00
- Revenue This Year
- FENC $2.68
- NKSH $1.17
- Revenue Next Year
- FENC $71.63
- NKSH $9.78
- P/E Ratio
- FENC N/A
- NKSH $18.89
- Revenue Growth
- FENC 123.69
- NKSH 2.21
- 52 Week Low
- FENC $3.96
- NKSH $23.75
- 52 Week High
- FENC $10.07
- NKSH $33.37
- Technical
- Relative Strength Index (RSI)
- FENC 51.33
- NKSH 52.22
- Support Level
- FENC $5.85
- NKSH $25.16
- Resistance Level
- FENC $6.61
- NKSH $26.83
- Average True Range (ATR)
- FENC 0.36
- NKSH 0.81
- MACD
- FENC 0.06
- NKSH 0.14
- Stochastic Oscillator
- FENC 54.20
- NKSH 60.32
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.